Vendor Decision Sprint
Turn one live assay, study, or outsourced workstream into a vendor-ready scope, a researched likely-fit field, sharper RFI questions, and an owner-ready comparison memo.
PhocaX services
Choose the path that matches the decision in front of you.
PhocaX has two current buyer-facing starting points: help for a biotech team choosing an outside partner, and help for a CRO or research vendor making one credible capability easier to evaluate. Other focused work remains available when it is the smallest useful next step.
Scientific Buyer Clarity
Make one credible scientific capability, service, website, or proof path easier for likely-fit buyers to understand, evaluate, and act on.
Focused Research Brief
Turn one defined market, competitor, technical, or opportunity question into a sourced, reviewable brief with decisions and watch items separated from noise.
Workflow Systems Sprint
Map one repeated operating bottleneck, clean the process, and define a safer automation or internal-tool target before expensive build work begins.
Specialized partner capability
In vivo receptor-occupancy studies, delivered by Kesla.
Kesla Translational Models owns and performs the laboratory work. PhocaX helps identify and qualify credible receptor-occupancy opportunities, then supports an introduction so Kesla can decide scientific fit, current availability, study scope, quote, and execution.
This is a partner capability, not a PhocaX laboratory service. No study is available or accepted until Kesla confirms it.
Working boundary
Small first pass. Clear owner. Reviewable output.
- Each engagement starts with one live problem and one defined first artifact.
- Claims and vendor signals remain traceable to available evidence.
- Scientific, quality, legal, regulatory, procurement, and investment decisions remain with the client and qualified advisors.
Not sure where it fits?
Send the real problem.
We’ll route it to the smallest useful first step—or say plainly when PhocaX is not the right fit.